Real-world safety and effectiveness of vosoritide: Results from an early access program in France

被引:0
|
作者
Cormier-Daire, Valerie [1 ]
Edouard, Thomas [2 ]
Isidor, Bertrand [3 ]
Cohen, Shelda [4 ]
Mukherjee, Swati [4 ]
Pimenta, Jeanne [4 ]
Lhaneche, Leila [5 ]
Rossi, Massimiliano [6 ,7 ]
Schaefer, Elise [8 ]
Goodman, Erin [9 ]
Sigaudy, Sabine [10 ]
Baujat, Genevieve [11 ]
机构
[1] Paris Ctr Univ, Imagine Inst, Necker Enfants Malad Hosp,INSERM,UMR 1163, Dept Clin Genet,Ctr Reference Constitut Bone Dis, Paris, France
[2] Toulouse Univ Hosp, Reference Ctr Rare Dis Calcium & Phosphate Metab, Paediat Res Unit,INSERM,U1301, ERN BOND,OSCAR Network,Childrens Hosp,RESTORE, Toulouse, France
[3] CHU Nantes, Nantes, France
[4] BioMarin UK Ltd, London, England
[5] BioMarin France, Paris, France
[6] Hosp Civils Lyon, Serv Genet, Lyon, France
[7] UCBL1, INSERM, U1028, CNRS,UMR5292,CRNL,GENDEV Team, Lyon, France
[8] Hop Hautepierre, CHU Strasbourg, Strasbourg, France
[9] BioMarin Pharmaceut Inc, Novato, CA USA
[10] Hop Timone Enfant, Dept Genet Med, Marseille, France
[11] Enfants Malad Hop Necker Enfants Malad, Hop Necker, Paris, France
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
RFC4.5
引用
收藏
页码:90 / 90
页数:1
相关论文
共 50 条
  • [1] Real-world experience with Vosoritide for achondroplasia: interim findings from an early access programme in France
    Cormier-Daire, Valerie
    Cohen, Shelda
    Edouard, Thomas
    Isidor, Bertrand
    Mukherjee, Swati
    Pimenta, Jeanne
    Rossi, Massimiliano
    Schaefer, Elise
    Sigaudy, Sabine
    Baujat, Genevieve
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 308 - 309
  • [2] From an early access program to real-world cenobamate use
    Thomas, R.
    EPILEPSIA, 2023, 64 : 4 - 5
  • [3] Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
    Villanueva, Vicente
    Santos-Carrasco, Daniel
    Cabezudo-Garcia, Pablo
    Gomez-Ibanez, Asier
    Garces, Mercedes
    Serrano-Castro, Pedro
    Castro-Vilanova, Maria D.
    Sayas, Debora
    Lopez-Gonzalez, Francisco J.
    Rodriguez-Osorio, Xiana
    Torres-Gaona, Gustavo
    Saiz-Diaz, Rosa A.
    Hampel, Kevin G.
    Martinez-Ferri, Meritxell
    Aguilar-Amat, Maria J.
    Mercedes-Alvarez, Blanca
    Garcia-Morales, Vanessa
    del Villar-Igea, Ana
    Massot-Tarrus, Andreu
    Rodriguez-Uranga, Juan J.
    EPILEPSIA OPEN, 2023, 8 (03) : 918 - 929
  • [4] Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study
    Barlesi, Fabrice
    Dixmier, Adrien
    Debieuvre, Didier
    Raspaud, Christophe
    Auliac, Jean-Bernard
    Benoit, Nicolas
    Bombaron, Pierre
    Moro-Sibilot, Denis
    Audigier-Valette, Clarisse
    Asselain, Bernard
    Egenod, Thomas
    Rabeau, Audrey
    Fayette, Jerome
    Sanchez, Myriam Locatelli
    Labourey, Jean-Luc
    Westeel, Virginie
    Lamoureux, Pauline
    Cotte, Francois-Emery
    Allan, Victoria
    Daumont, Melinda
    Dumanoir, Juliette
    Reynaud, Dorothee
    Calvet, Christophe Yannick
    Ozan, Nicolas
    Perol, Maurice
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [5] EVALUATION OF REAL-WORLD DATA COLLECTION AND EVIDENCE GENERATION FROM EARLY ACCESS PROGRAM
    Stein, D.
    Soni, M.
    VALUE IN HEALTH, 2018, 21 : S402 - S402
  • [6] Real-world effectiveness and safety of alirocumab
    Mondelo Garcia, C.
    Garcia Queiruga, M.
    Balea Filgueiras, J.
    Fernandez Bargiela, N.
    Gimenez Arufe, V.
    Fernandez Oliveira, C.
    Martin Herranz, M. I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 377 - 378
  • [7] Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program
    Albiges, Laurence
    Flechon, Aude
    Chevreau, Christine
    Topart, Delphine
    Gravis, Gwenaelle
    Oudard, Stephane
    Tourani, Jean M.
    Geoffrois, Lionnel
    Meriaux, Emeline
    Thiery-Vuillemin, Antoine
    Barthelemy, Philippe
    Ladoire, Sylvain
    Laguerre, Brigitte
    Perrot, Valerie
    Billard, Anais
    Escudier, Bernard
    Gross-Goupil, Marine
    EUROPEAN JOURNAL OF CANCER, 2021, 142 : 102 - 111
  • [8] REAL-WORLD EXPERIENCE OF GENERALIZED LIPODYSTROPHY PATIENTS ENROLLED IN THE METRELEPTIN EARLY ACCESS PROGRAM: INITIAL RESULTS
    Cook, K.
    Stears, A.
    Araujo-Vilar, D.
    Santini, F.
    O'Rahilly, S.
    Ceccarini, G.
    Frois, C.
    Bradt, P.
    Savage, D.
    VALUE IN HEALTH, 2018, 21 : S437 - S437
  • [9] Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
    Corrigan-Curay, Jacqueline
    Sacks, Leonard
    Woodcock, Janet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 867 - 868
  • [10] Effectiveness and safety of ocrelizumab and ofatumumab: first results from a German multicenter real-world cohort
    Wolff, Stephanie
    Rolfes, Leoni
    Pawlitzki, Marc
    Kleinschnitz, Konstanze
    Ruck, Tobias
    Huttner, Hagen
    Kleinschnitz, Christoph
    Pul, Refik
    Meuth, Sven
    Pfeuffer, Steffen
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 335 - 335